Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Genetic Technologies ( (AU:GTG) ) has shared an update.
Genetic Technologies Limited has announced the quotation of 26,493,450 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the company’s financial flexibility and operational capacity.
More about Genetic Technologies
Genetic Technologies Limited operates in the biotechnology industry, focusing on genetic testing and diagnostics. The company is known for its development of predictive genetic tests, which are aimed at assessing the risk of various diseases, thereby contributing to personalized healthcare solutions.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.45M
For detailed information about GTG stock, go to TipRanks’ Stock Analysis page.